How does empagliflozin improve arterial stiffness in patients with type 2 diabetes mellitus?
Bosch A, Ott C, Jung S, Striepe K, Karg MV, Kannenkeril D, Dienemann T, Schmieder R (2018)
Publication Type: Conference contribution
Publication year: 2018
Journal
Publisher: OXFORD UNIV PRESS
City/Town: OXFORD
Pages Range: 869-869
Conference Proceedings Title: EUROPEAN HEART JOURNAL
Event location: Munich
DOI: 10.1093/eurheartj/ehy563.4325
Authors with CRIS profile
Christian Ott
Medizinische Fakultät
Susan Jung
Department of Paediatrics and Adolescent Medicine
Kristina Striepe
Professur für Innere Medizin (Nephrologie)
Roland Schmieder
Professur für Innere Medizin (Nephrologie)
How to cite
APA:
Bosch, A., Ott, C., Jung, S., Striepe, K., Karg, M.V., Kannenkeril, D.,... Schmieder, R. (2018). How does empagliflozin improve arterial stiffness in patients with type 2 diabetes mellitus? In EUROPEAN HEART JOURNAL (pp. 869-869). Munich, DE: OXFORD: OXFORD UNIV PRESS.
MLA:
Bosch, A., et al. "How does empagliflozin improve arterial stiffness in patients with type 2 diabetes mellitus?" Proceedings of the European-Society-of-Cardiology Congress, Munich OXFORD: OXFORD UNIV PRESS, 2018. 869-869.
BibTeX: Download